Anti-angiogenic compositions and methods of use
First Claim
Patent Images
1. A stent comprising(a) a balloon expandable coronary stent;
- and(b) paclitaxel, in an amount that when tested in a chick chorioallantoic membrane assay is anti-angiogenic.
10 Assignments
0 Petitions
Accused Products
Abstract
The present invention is directed to a stent comprising
- (a) a balloon expandable coronary stent; and
- (b) paclitaxel, in an amount that when tested in a chick chorioallantoic membrane assay is anti-angiogenic.
-
Citations
17 Claims
-
1. A stent comprising
(a) a balloon expandable coronary stent; - and
(b) paclitaxel, in an amount that when tested in a chick chorioallantoic membrane assay is anti-angiogenic. - View Dependent Claims (2, 16, 17)
- and
-
3. A stent comprising
(a) a balloon expandable coronary stent; - and
(b) paclitaxel or an analog thereof, in an amount that when tested in a chick chorioallantoic membrane assay is anti-angiogenic. - View Dependent Claims (4)
- and
-
5. A stent comprising
(a) a balloon expandable coronary stent and (b) a composition comprising paclitaxel, wherein the composition when tested in a chick chorioallantoic membrane assay is anti-angiogenic.
-
6. A vascular stent comprising
an expandable stent; - and
paclitaxel, wherein the vascular stent contains paclitaxel in an effective amount which is capable of inhibiting angiogenesis in vivo. - View Dependent Claims (7, 8)
- and
-
9. A vascular stent prepared from components comprising:
-
(a) an expandable scaffold; and (b) paclitaxel, in an amount that when tested in a chick chorioallantoic membrane assay is anti-angiogenic. - View Dependent Claims (10, 11, 12)
-
-
13. A vascular stent prepared from components comprising:
-
(a) a balloon expandable scaffold; and (b) a composition comprising paclitaxel, wherein the composition when tested in a chick chorioallantoic membrane assay is anti-angiogenic. - View Dependent Claims (14, 15)
-
Specification